慢性阻塞性肺疾病合并焦慮抑郁的研究進展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

葉志鵬 ,  陳磊

四川大學華西醫院呼吸與危重癥醫學科（四川成都 610041）;

Corresponding?author：

陳磊, Email: lchens@126.com

Keywords：

DOI：

10.7507/1671-6205.201811011

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 葉志鵬, 陳磊. 慢性阻塞性肺疾病合并焦慮抑郁的研究進展. Chinese Journal of Respiratory and Critical Care Medicine, 2019, 18(5): 491-494. doi: 10.7507/1671-6205.201811011 Copy

1.	Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health. Lancet, 2018, 391(10131): 1706-1717.
2.	Garvey C, Criner GJ. Impact of comorbidities on the treatment of chronic obstructive pulmonary disease. Am J Med, 2018, 131(9): 23-29.
3.	王新安, 劉鮮艷, 歐陽修河. 慢性阻塞性肺疾病合并骨質疏松癥研究進展. 中國呼吸與危重監護雜志, 2017, 16(6): 627-630.
4.	Yohannes AM, Kaplan A, Hanania NA. Anxiety and depression in chronic obstructive pulmonary disease: Recognition and management. Clev Clin J Med, 2018, 85(2 Suppl 1): S11-S18.
5.	韓萍, 姜文青, 殷彬, 等. COPD合并抑郁癥的研究進展. 中國衛生產業, 2016, 13(6): 196-198.
6.	Regvat J, Mitek A, Vegnuti M, et al. Anxiety and depression during hospital treatment of exacerbation of chronic obstructive pulmonary disease. J Int Med Res, 2011, 39(3): 1028-1038.
7.	Montserrat-Capdevila J, Godoy P, Marsal JR, et al. Mental disorders in chronic obstructive pulmonary diseases. Perspect Psychiatr C, 2018, 54(3): 398-404.
8.	Atlantis E, Fahey P, Cochrane B, et al. Bidirectional associations between clinically relevant depression or anxiety and COPD: A systematic review and meta-analysis. Chest, 2013, 144(3): 766-777.
9.	文富強. 重視慢性阻塞性肺疾病的合并癥. 中華肺部疾病雜志(電子版), 2013, 6(2): 99-102.
10.	Pelgrim CE, Peterson JD, Gosker HR, et al. Psychological co-morbidities in COPD: targeting systemic inflammation, a benefit for both?. Eur J Pharmacol, 2019, 842: 99-110.
11.	Zilz C, Blaas SH, Pfeifer M, et al. Mental health, serum biomarkers and survival in severe COPD: a pilot study. Multidiscip Respir Med, 2015, 11: 3.
12.	Pumar MI, Gray CR, Walsh JR, et al. Anxiety and depression-Important psychological comorbidities of COPD. J Thorac Dis, 2014, 6(11): 1615-1631.
13.	Al-shair K, Kolsum U, Dockry R, et al. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res, 2011, 12: 3.
14.	Xu W, Collet J, Shapiro S, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Resp Crit Care, 2008, 178(9): 913-920.
15.	Usmani ZA, Carson KV, Heslop K, et al. Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Db Syst Rev, 2017, 9(3): D10673.
16.	Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res, 2017, 18(1): 67.
17.	Xiao T, Qiu H, Chen Y, et al. Prevalence of anxiety and depression symptoms and their associated factors in mild COPD patients from community settings, Shanghai, China: a cross-sectional study. BMC Psychiatry, 2018, 18(1): 89.
18.	Lou P, Zhu Y, Chen P, et al. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med, 2012, 12(1): 53.
19.	Varol Y, Anar C, ?imen P, et al. Sex-related differences in COPD Assessment Test scores of COPD populations with or without significant anxiety and/or depression. Turk J Med SCI, 2017, 47(1): 61-68.
20.	Zhang H, Wang X, Lin J, et al. Grey and white matter abnormalities in chronic obstructive pulmonary disease: a case-control study. BMJ Open, 2012, 2(2): e844.
21.	Johnson PL, Samuels BC, Fitz SD, et al. Activation of the orexin 1 receptor is a critical component of CO₂-mediated anxiety and hypertension but not bradycardia. Neuropsychopharmacol, 2012, 37(8): 1911-1922.
22.	文富強, 陳磊. GOLD 2017 更新與中國慢阻肺臨床實踐. 西部醫學, 2018, (1): 1-2.
23.	Brook A, Zhang C. The role of personal attributes in the genesis and progression of lung disease and cigarette smoking. Am J Public Health, 2013, 103(5): 931-937.
24.	Sundar IK, Yao H, Huang Y, et al. Serotonin and corticosterone rhythms in mice exposed to cigarette smoke and in patients with COPD: implication for COPD-associated neuropathogenesis. PLoS One, 2014, 9(2): e87999.
25.	Ghaderi A, Nasehghafoori P, Rasouli-Azad M, et al. Examining of thallium in cigarette smokers. Biol Trace Elem Res, 2018, 182(2): 224-230.
26.	Altemus M, Sarvaiya N, Neill Epperson C. Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrin, 2014, 35(3): 320-330.
27.	Zhang Q, Liao J, Liao X, et al. Disease knowledge level is a noteworthy risk factor of anxiety and depression in patients with chronic obstructive pulmonary disease: a cross-sectional study. BMC Pulm Med, 2014, 14(1): 92.
28.	Yu T, Ter Riet G, Puhan MA, et al. Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease: a cohort study. NPJ Prim Care Respir Med, 2017, 27(1): 36.
29.	Hyun MK, Lee NR, Jang EJ, et al. Effect of inhaled drugs on anxiety and depression in patients with chronic obstructive pulmonary disease: a prospective observational study. Int J Chron Obstruct Pulmon Dis, 2016, 11(1): 747-754.
30.	Jácome C, Figueiredo D, Gabriel R, et al. Predicting anxiety and depression among family carers of people with chronic obstructive pulmonary disease. Int Psychogeriatr, 2014, 26(7): 1191-1199.
31.	Mi E, Mi E, Ewing G, et al. Associations between the psychological health of patients and carers in advanced COPD. Int J Chronic Obstruct Obst Dis, 2017, 12: 2813-2821.
32.	中華醫學會神經病學分會神經心理學與行為神經病學組. 綜合醫院焦慮、抑郁與軀體化癥狀診斷治療的專家共識. 中華神經科雜志, 2016, 49(12): 908-917.
33.	Vanfleteren LEGW, Spruit MA, Wouters EFM, et al. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir Med, 2016, 4(11): 911-924.
34.	Yawn B, Kim V. COPD in primary care: Key considerations for optimized management: Treatment options for stable chronic obstructive pulmonary disease: Current recommendations and unmet needs. J Fam Pract, 2018, 67(2 Suppl): S28-S37.
35.	Schuler M, Strohmayer M, Muhlig S, et al. Assessment of depression before and after inpatient rehabilitation in COPD patients: psychometric properties of the German version of the Patient Health Questionnaire (PHQ-9/PHQ-2). J Affect Disord, 2018, 232: 268-275.
36.	Livermore N, Dimitri A, Sharpe L, et al. Cognitive behaviour therapy reduces dyspnoea ratings in patients with chronic obstructive pulmonary disease (COPD). Respir Physiol Neurobiol, 2015, 216: 35-42.
37.	姚文飛, 屠春林, 趙開順, 等. 慢性阻塞性肺疾病的肺康復研究進展. 臨床肺科雜志, 2017, 22(2): 347-350.
38.	da Silva GP, Nascimento FA, Macêdo TP, et al. Religious coping and religiosity in patients with COPD following pulmonary rehabilitation. Int J Chronic Obstruct Obst Dis, 2018, 13: 175-181.
39.	Wang L, M?rtensson J, Zhao Y, et al. Experiences of a health coaching self-management program in patients with COPD: a qualitative content analysis. Int J Chron Obstruct Pulmon Dis, 2018, 13: 1527-1536.
40.	He Y, Zheng Y, Xu C, et al. Sertraline hydrochloride treatment for patients with stable chronic obstructive pulmonary disease complicated with depression: a randomized controlled trial. Clin Respir J, 2016, 10(3): 318-325.
41.	Rosa F, Bagnasco A, Ghirotto L, et al. Experiences of older people following an acute exacerbation of chronic obstructive pulmonary disease: a phenomenological study. J Clin Nurs, 2018, 27(5-6): e1110-e1119.

1. Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health. Lancet, 2018, 391(10131): 1706-1717.
2. Garvey C, Criner GJ. Impact of comorbidities on the treatment of chronic obstructive pulmonary disease. Am J Med, 2018, 131(9): 23-29.
3. 王新安, 劉鮮艷, 歐陽修河. 慢性阻塞性肺疾病合并骨質疏松癥研究進展. 中國呼吸與危重監護雜志, 2017, 16(6): 627-630.
4. Yohannes AM, Kaplan A, Hanania NA. Anxiety and depression in chronic obstructive pulmonary disease: Recognition and management. Clev Clin J Med, 2018, 85(2 Suppl 1): S11-S18.
5. 韓萍, 姜文青, 殷彬, 等. COPD合并抑郁癥的研究進展. 中國衛生產業, 2016, 13(6): 196-198.
6. Regvat J, Mitek A, Vegnuti M, et al. Anxiety and depression during hospital treatment of exacerbation of chronic obstructive pulmonary disease. J Int Med Res, 2011, 39(3): 1028-1038.
7. Montserrat-Capdevila J, Godoy P, Marsal JR, et al. Mental disorders in chronic obstructive pulmonary diseases. Perspect Psychiatr C, 2018, 54(3): 398-404.
8. Atlantis E, Fahey P, Cochrane B, et al. Bidirectional associations between clinically relevant depression or anxiety and COPD: A systematic review and meta-analysis. Chest, 2013, 144(3): 766-777.
9. 文富強. 重視慢性阻塞性肺疾病的合并癥. 中華肺部疾病雜志(電子版), 2013, 6(2): 99-102.
10. Pelgrim CE, Peterson JD, Gosker HR, et al. Psychological co-morbidities in COPD: targeting systemic inflammation, a benefit for both?. Eur J Pharmacol, 2019, 842: 99-110.
11. Zilz C, Blaas SH, Pfeifer M, et al. Mental health, serum biomarkers and survival in severe COPD: a pilot study. Multidiscip Respir Med, 2015, 11: 3.
12. Pumar MI, Gray CR, Walsh JR, et al. Anxiety and depression-Important psychological comorbidities of COPD. J Thorac Dis, 2014, 6(11): 1615-1631.
13. Al-shair K, Kolsum U, Dockry R, et al. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res, 2011, 12: 3.
14. Xu W, Collet J, Shapiro S, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Resp Crit Care, 2008, 178(9): 913-920.
15. Usmani ZA, Carson KV, Heslop K, et al. Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Db Syst Rev, 2017, 9(3): D10673.
16. Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res, 2017, 18(1): 67.
17. Xiao T, Qiu H, Chen Y, et al. Prevalence of anxiety and depression symptoms and their associated factors in mild COPD patients from community settings, Shanghai, China: a cross-sectional study. BMC Psychiatry, 2018, 18(1): 89.
18. Lou P, Zhu Y, Chen P, et al. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med, 2012, 12(1): 53.
19. Varol Y, Anar C, ?imen P, et al. Sex-related differences in COPD Assessment Test scores of COPD populations with or without significant anxiety and/or depression. Turk J Med SCI, 2017, 47(1): 61-68.
20. Zhang H, Wang X, Lin J, et al. Grey and white matter abnormalities in chronic obstructive pulmonary disease: a case-control study. BMJ Open, 2012, 2(2): e844.
21. Johnson PL, Samuels BC, Fitz SD, et al. Activation of the orexin 1 receptor is a critical component of CO₂-mediated anxiety and hypertension but not bradycardia. Neuropsychopharmacol, 2012, 37(8): 1911-1922.
22. 文富強, 陳磊. GOLD 2017 更新與中國慢阻肺臨床實踐. 西部醫學, 2018, (1): 1-2.
23. Brook A, Zhang C. The role of personal attributes in the genesis and progression of lung disease and cigarette smoking. Am J Public Health, 2013, 103(5): 931-937.
24. Sundar IK, Yao H, Huang Y, et al. Serotonin and corticosterone rhythms in mice exposed to cigarette smoke and in patients with COPD: implication for COPD-associated neuropathogenesis. PLoS One, 2014, 9(2): e87999.
25. Ghaderi A, Nasehghafoori P, Rasouli-Azad M, et al. Examining of thallium in cigarette smokers. Biol Trace Elem Res, 2018, 182(2): 224-230.
26. Altemus M, Sarvaiya N, Neill Epperson C. Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrin, 2014, 35(3): 320-330.
27. Zhang Q, Liao J, Liao X, et al. Disease knowledge level is a noteworthy risk factor of anxiety and depression in patients with chronic obstructive pulmonary disease: a cross-sectional study. BMC Pulm Med, 2014, 14(1): 92.
28. Yu T, Ter Riet G, Puhan MA, et al. Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease: a cohort study. NPJ Prim Care Respir Med, 2017, 27(1): 36.
29. Hyun MK, Lee NR, Jang EJ, et al. Effect of inhaled drugs on anxiety and depression in patients with chronic obstructive pulmonary disease: a prospective observational study. Int J Chron Obstruct Pulmon Dis, 2016, 11(1): 747-754.
30. Jácome C, Figueiredo D, Gabriel R, et al. Predicting anxiety and depression among family carers of people with chronic obstructive pulmonary disease. Int Psychogeriatr, 2014, 26(7): 1191-1199.
31. Mi E, Mi E, Ewing G, et al. Associations between the psychological health of patients and carers in advanced COPD. Int J Chronic Obstruct Obst Dis, 2017, 12: 2813-2821.
32. 中華醫學會神經病學分會神經心理學與行為神經病學組. 綜合醫院焦慮、抑郁與軀體化癥狀診斷治療的專家共識. 中華神經科雜志, 2016, 49(12): 908-917.
33. Vanfleteren LEGW, Spruit MA, Wouters EFM, et al. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir Med, 2016, 4(11): 911-924.
34. Yawn B, Kim V. COPD in primary care: Key considerations for optimized management: Treatment options for stable chronic obstructive pulmonary disease: Current recommendations and unmet needs. J Fam Pract, 2018, 67(2 Suppl): S28-S37.
35. Schuler M, Strohmayer M, Muhlig S, et al. Assessment of depression before and after inpatient rehabilitation in COPD patients: psychometric properties of the German version of the Patient Health Questionnaire (PHQ-9/PHQ-2). J Affect Disord, 2018, 232: 268-275.
36. Livermore N, Dimitri A, Sharpe L, et al. Cognitive behaviour therapy reduces dyspnoea ratings in patients with chronic obstructive pulmonary disease (COPD). Respir Physiol Neurobiol, 2015, 216: 35-42.
37. 姚文飛, 屠春林, 趙開順, 等. 慢性阻塞性肺疾病的肺康復研究進展. 臨床肺科雜志, 2017, 22(2): 347-350.
38. da Silva GP, Nascimento FA, Macêdo TP, et al. Religious coping and religiosity in patients with COPD following pulmonary rehabilitation. Int J Chronic Obstruct Obst Dis, 2018, 13: 175-181.
39. Wang L, M?rtensson J, Zhao Y, et al. Experiences of a health coaching self-management program in patients with COPD: a qualitative content analysis. Int J Chron Obstruct Pulmon Dis, 2018, 13: 1527-1536.
40. He Y, Zheng Y, Xu C, et al. Sertraline hydrochloride treatment for patients with stable chronic obstructive pulmonary disease complicated with depression: a randomized controlled trial. Clin Respir J, 2016, 10(3): 318-325.
41. Rosa F, Bagnasco A, Ghirotto L, et al. Experiences of older people following an acute exacerbation of chronic obstructive pulmonary disease: a phenomenological study. J Clin Nurs, 2018, 27(5-6): e1110-e1119.

Previous Article
彌漫性肺骨化癥一例
Next Article
青蒿琥酯對哮喘治療作用的研究進展

Chinese Journal of Respiratory and Critical Care Medicine

慢性阻塞性肺疾病合并焦慮抑郁的研究進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content